Inmunología
Hospital Universitari de Bellvitge
l'Hospitalet de Llobregat, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitari de Bellvitge (12)
2024
2021
-
Identification of Recent Tuberculosis Exposure Using QuantiFERON-TB Gold Plus, a Multicenter Study
Microbiology Spectrum, Vol. 9, Núm. 3
2018
-
QuantiFERON-TB Gold In-Tube as a Confirmatory Test for Tuberculin Skin Test in Tuberculosis Contact Tracing: A Noninferiority Clinical Trial
Clinical Infectious Diseases, Vol. 66, Núm. 3, pp. 396-403
2017
-
Infection control, genetic assessment of drug resistance and drug susceptibility testing in the current management of multidrug/extensively-resistant tuberculosis (M/XDR-TB) in Europe: A tuberculosis network European Trialsgroup (TBNET) study
Respiratory Medicine, Vol. 132, pp. 68-75
-
Response to bile salts in clinical strains of Acinetobacter baumannii lacking the adeABC efflux pump: Virulence associated with quorum sensing
Frontiers in Cellular and Infection Microbiology, Vol. 7, Núm. MAY
2016
-
Detection of interleukin-2 is not useful for distinguishing between latent and active tuberculosis in clinical practice: a prospective cohort study
Clinical Microbiology and Infection, Vol. 22, Núm. 12, pp. 1007.e1-1007.e5
-
Executive Summary of the Guidelines for the Use of interferon-gamma Release Assays in the Diagnosis of Tuberculosis Infection
Archivos de Bronconeumologia, Vol. 52, Núm. 9, pp. 477-481
-
Executive summary of the guidelines for the use of interferon-γ release assays in the diagnosis of tuberculosis infection
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 34, Núm. 5, pp. 304-308
-
Factors associated with fatality during the intensive phase of anti-tuberculosis treatment
PLoS ONE, Vol. 11, Núm. 8
-
Guidelines for the use of interferon-γ release assays in the diagnosis of tuberculosis infection
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 34, Núm. 5, pp. 303.e1-303.e13
2011
-
Diagnosis of tuberculosis infection by tuberculin skin test and a whole-blood interferon-γ release assay in patients considered for anti-tumor necrosis factor-α therapy
Diagnostic Microbiology and Infectious Disease, Vol. 71, Núm. 1, pp. 57-65
2010
-
Treatment completion in latent tuberculosis infection at specialist tuberculosis units in Spain
International Journal of Tuberculosis and Lung Disease, Vol. 14, Núm. 6, pp. 701-707